Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 5/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | CA12 | O43570 | 4/20 | 0.62 |
| ▸ | CA9 | Q16790 | 4/20 | 0.62 |
| ▸ | CA1 | P00915 | 3/20 | 0.62 |
| ▸ | CA2 | P00918 | 3/20 | 0.62 |
| ▸ | CA3 | P07451 | 3/20 | 0.62 |
| ▸ | CA4 | P22748 | 3/20 | 0.62 |
| ▸ | CA6 | P23280 | 3/20 | 0.62 |
| ▸ | CA5A | P35218 | 3/20 | 0.62 |
| ▸ | CA7 | P43166 | 3/20 | 0.62 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.62 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.62 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1471666 | 0.90 | SMN1; SMN2 (0.78) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL27313733 | 0.87 | CA12 (0.53) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL7543999 | 0.87 | HTT (0.51) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL28031906 | 0.87 | CA12 (0.69) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL20828073 | 0.86 | CA12 (0.53) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL18029396 | 0.85 | CA9 (0.64) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL14228900 | 0.84 | CA12 (0.62) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL11498983 | 0.84 | CA9 (0.57) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL14229664 | 0.82 | CA12 (0.67) | HTTLMNASMN1; SMN2CA12CA9 | |
| SCHEMBL4589706 | 0.81 | SMN1; SMN2 (0.63) | HTTLMNASMN1; SMN2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719413-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | Animol Discovery, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092070-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | ANIMOL DISCOVERY INC (US) | 2026-04-02 | — | — | US | disclosed |
| WO-2024246837-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | ANIMOL DISCOVERY, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| EP-2994457-B1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | UNIV CALIFORNIA (US) | 2021-01-06 | — | — | EP | disclosed |
| US-20180162827-A1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-06-14 | — | — | US | disclosed |
| US-9840483-B2 | Radiomitigating pharmaceutical formulations | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-12 | — | — | US | disclosed |
| US-9783515-B2 | Radiomitigating pharmaceutical formulations | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-10-10 | — | — | US | disclosed |
| US-9783515-B2 | Radiomitigating pharmaceutical formulations | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-10-10 | — | — | US | disclosed |
| US-9783515-B2 | Radiomitigating pharmaceutical formulations | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160221976-A1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-08-04 | — | — | US | disclosed |
| US-20160221976-A1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-08-04 | — | — | US | disclosed |
| US-20160090369-A1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-31 | — | — | US | disclosed |
| US-6407120-B1 | ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS | PFIZER INC. | 2002-06-18 | — | — | US | disclosed |
| EP-1033366-A2 | Amide derivatives useful as Neuropeptide Y (NPY) antagonists | Pfizer Products Inc. (US) | 2000-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160221976-A1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | LIPG, SGMS2, SGMS1 | HTT 4155/4885LMNA 1838/4885SMN1; SMN2 3642/4885 |
| US-20180162827-A1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | LIPG, SGMS2, SGMS1 | HTT 4155/4885LMNA 1838/4885SMN1; SMN2 3642/4885 |
| US-20260092070-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | JAK1, JAK3, JAK2 | HTT 3902/4885LMNA 4444/4885SMN1; SMN2 4009/4885 |
| US-20160090369-A1 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | LIPG, SGMS2, SGMS1 | HTT 4155/4885LMNA 1838/4885SMN1; SMN2 3642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.